U-M Health Frankel CVC

RT @UMIntMed: Faculty Spotlight! From genetic discovery to better patient care. Learn how @SanthiKGanesh is advancing research into rare vascular diseases and working to turn scientific insights into new possibilities for diagnosis and treatment:

After the @Eagles announced Jalen Hurts would miss the season due to blood clots in his lungs, Michigan Medicine hematologist Dr. Jordan K. Schaefer spoke with @espn about diagnosis, treatment and recovery.

Click here to read the full conversation with @Tim_McManus:

RT @venkmurthy: Gene editing is rapidly advancing in clinical trials for many different diseases Out now in @JAMAInternalMed is our proposed framework for when *should* this class of therapies be used @EricSmithMD @umichCVC

RT @FrankMDavisMD: Great talk by Andrew Huang and Craig Brown at Midwestern Vascular Surgery! Important to achieve long term medical adherence yo improve dissection outcomes. @umichCVC @MWVSSociety @UMichSurgery

Congratulations to Dr. @venkmurthy on his appointment to the U.S. Preventive Services Task Force (USPSTF). Murthy, a cardiologist and health innovation researcher at the Frankel Cardiovascular Center, is one of eight new members selected to serve on the task force.

“I am honored by the opportunity to serve the nation by applying gold-standard science to improve the health of all Americans,” Murthy said. Click this link to learn more:

RT @RaymondPashunMD: Proud of our @umichmedicine @umichCVC team’s new @JACCJournals work: an EHR nudge helped improve recognition & escalation of #normotensive #cardiogenicshock. Alert engagement ⬆️ rate of #CICU consult w/in 12 hours. #qualityimprovement #digitalhealth

Congratulations, Dr. Murthy! #GoBlue

RT @victor_moles: Just a few weeks left until PH Update 2026 in Ann Arbor! ⏳🫁 If you treat or manage pulmonary hypertension, this full-day symposium brings together leading clinical experts to discuss the latest management strategies, emerging therapies, and clinical trials. 🗓️ Friday, Oct 2 📍 Ann Arbor, MI 🎓 Up to 7.0 CME/CNE/CPE credits Spaces are filling up—reserve your seat today: @anjalivaidyaMD @heresi_gustavo @umichCVC @umichmedicine @ValMcLaughlinMD @SandeepSahayMD @jeanlucvachiery @OSitbon @CHESTPulmCardio @AlbertaPHdoc @atscommunity @PulmonaryNews @PHAssociation @yreddyhf

Is coffee good for your heart? A preventive cardiologist breaks down what the latest research says about coffee, caffeine and cardiovascular health.

RT @FrankMDavisMD: Excited to share the Davis Lab is now NIH R01-funded! We'll be investigating epigenetic regulation of macrophage inflammation in abdominal aortic aneurysm development. Grateful for this opportunity to dig deeper into vascular inflammation biology. 🧬🔬

RT @UMichSurgery: Congratulations to Robert Beaulieu, MD, MSE, on his new role as the Frankel Cardiovascular Center MPlan Operating Room Surgical Director!

RT @NYUDocs: Do you have questions about DVTs or PEs? Vascular Surgery is live. @thevasculardr is talking with @GBarnesMD @umichCVC. Call 877-698-3627 or email docs@siriusxm.com with your questions. Stream it here:

RT @UMIntMed: We are proud to be recognized by the @American_Heart for achieving the #TargetAS Honor Roll award for our commitment to improving care for this undertreated heart valve disease. @umichCVC Learn more 👉

RT @JGarbincius: Congrats to Garbincius Lab undergraduate Anika Patel for presenting her research at the Frankel Cardiovascular Center SURF Symposium this afternoon! Special thanks to @umichCVC and @AHA_Research for supporting this wonderful program!

Congratulations to Anand Singh, Ph.D., on receiving a $2.2 million R01 grant from the @NIH to investigate ways to reduce the cardiotoxic side effects associated with osimertinib, the only approved therapy for EGFR T790M-positive non-small cell lung cancer.

Up to 5% of patients on the drug experience serious cardiac events. Singh’s team will investigate the mechanisms that cause cardiotoxicity after osimertinib treatment, as well as possible therapeutic targets to prevent that damage. Learn more:

If you've been diagnosed with aortic valve disease, you have more treatment options than ever before. In a recent livestream, our experts discussed TAVR + SAVR, how they help patients choose the right treatment, & how the latest advances in valve technology are improving care.

Honored to serve the American people on the US Preventive Services Task Force I am looking forward to advising @HHSGov on preventive health measures 🇺🇸🇺🇸🇺🇸

RT @GAilawadiMD: We're excited to announce that we're accepting applications for an Advanced Heart Failure & Cardiac Transplant Surgeon to join us in Ann Arbor. Great team, top-tier facilities, and a mission that matters. Click the link below to learn more! @umichCVC